Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

human acellular dermal matrix

An allograft composed of sterile, decellularized regenerative human dermal tissue matrix, with soft tissue reconstructive and transplantation purposes. In this human acellular dermal matrix (hADM), which is composed of the dermal layer and extracellular matrix of thin layers of donated skin that have had the epidermal layer removed, the donor cellular material is removed, which minimizes immunological response in ADM recipients. The hADM retains native growth factors, collagen and elastin. Using hADM to support tissue expanders or implants for soft tissue reconstruction or to aid in wound healing, the matrix allows for rapid cellular proliferation and infiltration, integration of mesenchymal cells into the matrix and re-vascularization. This facilitates surgical reconstruction and protects against wound exposure and wound infection.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:D-ADM
human ADM
US brand name:DermACELL
Abbreviation:hADM
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search